Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

BACKGROUND: Circulating tumor cells (CTCs) have been shown to predict reduced survival outcomes in metastatic breast cancer. METHODS: CTCs were analyzed in 2026 patients with early breast cancer before adjuvant chemotherapy and in 1492 patients after chemotherapy using the CellSearch System. After i...

Descripción completa

Detalles Bibliográficos
Autores principales: Rack, Brigitte, Schindlbeck, Christian, Jückstock, Julia, Andergassen, Ulrich, Hepp, Philip, Zwingers, Thomas, Friedl, Thomas W. P., Lorenz, Ralf, Tesch, Hans, Fasching, Peter A., Fehm, Tanja, Schneeweiss, Andreas, Lichtenegger, Werner, Beckmann, Matthias W., Friese, Klaus, Pantel, Klaus, Janni, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112925/
https://www.ncbi.nlm.nih.gov/pubmed/24832787
http://dx.doi.org/10.1093/jnci/dju066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112925/
https://www.ncbi.nlm.nih.gov/pubmed/24832787
http://dx.doi.org/10.1093/jnci/dju066

Ejemplares similares